DrugDashboards

Telmisartan and Amlodipine

Telmisartan and Amlodipine · TELMISARTAN 80 mg/1; AMLODIPINE BESYLATE 5 mg/1 · Tablet · Oral · Alembic Pharmaceuticals Limited

NDC 46708-0186-06 · 60 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00378-1077-93) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$2.99per unit
middle half $1.76$4.59 · 4,409 plans · Apr 1, 2026
Est. net of rebates
≈ $2.99
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
80%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 85%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for telmisartan and amlodipine (oral solid) in the next 90 days

sole-source market · price up 6% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA205234
TE code
Approval date
Nov 17, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Telmisartan and Amlodipine (Tablet)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals LimitedTELMISARTAN 40 mg/1; AMLODIPINE BESYLATE 10 mg/1Aug 26, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 80 mg/1; AMLODIPINE BESYLATE 5 mg/1Aug 26, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 80 mg/1; AMLODIPINE BESYLATE 10 mg/1Aug 26, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 40 mg/1; AMLODIPINE BESYLATE 5 mg/1Aug 26, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 80 mg/1; AMLODIPINE BESYLATE 5 mg/1Aug 26, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 40 mg/1; AMLODIPINE BESYLATE 10 mg/1Aug 26, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 40 mg/1; AMLODIPINE BESYLATE 5 mg/1Aug 26, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 80 mg/1; AMLODIPINE BESYLATE 10 mg/1Aug 26, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 5 mg/1; AMLODIPINE BESYLATE 80 mg/1Jul 22, 2026Aug 19, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 5 mg/1; AMLODIPINE BESYLATE 40 mg/1Jul 22, 2026Aug 19, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 10 mg/1; AMLODIPINE BESYLATE 80 mg/1Jul 22, 2026Aug 19, 2026
Alembic Pharmaceuticals LimitedTELMISARTAN 10 mg/1; AMLODIPINE BESYLATE 40 mg/1Jul 22, 2026Aug 19, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 10 mg/1; AMLODIPINE BESYLATE 40 mg/1Jul 22, 2026Aug 19, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 10 mg/1; AMLODIPINE BESYLATE 80 mg/1Jul 22, 2026Aug 19, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 5 mg/1; AMLODIPINE BESYLATE 40 mg/1Jul 22, 2026Aug 19, 2026
Mylan Pharmaceuticals Inc.TELMISARTAN 5 mg/1; AMLODIPINE BESYLATE 80 mg/1Jul 22, 2026Aug 19, 2026
Alembic Pharmaceuticals LimitedAMLODIPINE BESYLATE 10 mg/1; TELMISARTAN 40 mg/1Jul 15, 2026Jul 15, 2026
Alembic Pharmaceuticals LimitedAMLODIPINE BESYLATE 5 mg/1; TELMISARTAN 80 mg/1Jul 15, 2026Jul 15, 2026
Alembic Pharmaceuticals LimitedAMLODIPINE BESYLATE 5 mg/1; TELMISARTAN 40 mg/1Jul 15, 2026Jul 15, 2026
Alembic Pharmaceuticals LimitedAMLODIPINE BESYLATE 10 mg/1; TELMISARTAN 80 mg/1Jul 15, 2026Jul 15, 2026
Mylan Pharmaceuticals Inc.AMLODIPINE BESYLATE 10 mg/1; TELMISARTAN 40 mg/1Jul 15, 2026Jul 15, 2026
Mylan Pharmaceuticals Inc.AMLODIPINE BESYLATE 5 mg/1; TELMISARTAN 40 mg/1Jul 15, 2026Jul 15, 2026
Mylan Pharmaceuticals Inc.AMLODIPINE BESYLATE 10 mg/1; TELMISARTAN 80 mg/1Jul 15, 2026Jul 15, 2026
Mylan Pharmaceuticals Inc.AMLODIPINE BESYLATE 5 mg/1; TELMISARTAN 80 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Telmisartan and Amlodipine — NDC 46708-0186-06," retrieved September 3, 2026, https://drugdashboards.com/drug/46708018606.

Free to cite with attribution — see how the data is put together.